Statistics
Publications
33
Citations
2.6K
H-Index
18
Active since
1991
John A. Zebala is an author at Syntrix Biosystems (United States) specializing in medicine, oncology, and pharmacology.
Publications per year
1991–2024
33
33
KRAS-IRF2 Axis Drives Immune Suppression and Immune Therapy Resistance in Colorectal Cancer
Wenting Liao, Michael J. Overman, Adam T. Boutin et al. · Cancer Cell · 2019 · 610 citations · Full text
Medicine, Cancer Biology, Oncology +16
Effective combinatorial immunotherapy for castration-resistant prostate cancer
Xin Lü, James W. Horner, Erin Paul et al. · Nature · 2017 · 547 citations · Full text
Inhibiting myeloid-derived suppressor cell trafficking enhances T cell immunotherapy
Lillian Sun, Paúl E. Clavijo, Yvette Robbins et al. · JCI Insight · 2019 · 232 citations · Full text
Medicine, Immunology, Oncology +17
Neutrophil content predicts lymphocyte depletion and anti-PD1 treatment failure in NSCLC
Julia Kargl, Xiaodong Zhu, Huajia Zhang et al. · JCI Insight · 2019 · 192 citations · Full text
Life Sciences, Immunology, Oncology +17
1–5 of 33